Understanding Real-Life Response to Lurbinectedin as Second Line Therapy in Patients with Extensive Stage Small-Cell Lung Cancer

被引：0
|
作者：
Curt, K. [1 ]
Rice, J. [1 ]
Qin, A. [1 ]
机构：
[1] Univ Michigan, Ann Arbor, MI USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Lurbinectedin; Real-life efficacy; Extensive Stage Small Cell Lung Cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP13.07-01
引用
收藏
页码：S705 / S706
页数：2
相关论文
共 50 条
  • [31] IMpower133: Exploratory Analysis of Maintenance Therapy in Patients With Extensive-Stage Small-Cell Lung Cancer
    Reck, M.
    Horn, L.
    Mok, T. S. K.
    Mansfield, A.
    De Boer, R.
    Losonczy, G.
    Sugawara, S.
    Dziadziuszko, R.
    Krzakowski, M.
    Smolin, A.
    Hochmair, M.
    Garassino, M.
    Castro, G.
    Bischoff, H.
    Cardona, A.
    Morris, S.
    Liu, S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S128 - S128
  • [32] Phase II trial with carboplatin and bendamustine in patients with extensive stage small-cell lung cancer
    Koester, Wolf
    Heider, Andrea
    Niederle, Norbert
    Wilke, Hansjochen
    Stamatis, Georgios
    Fischer, Juergen R.
    Koch, Jens A.
    Stahl, Michael
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (04) : 312 - 316
  • [33] The management of patients with extensive-stage small-cell lung cancer: A European survey of practice
    Haslett, K.
    De Ruysscher, D.
    Dziadziuszko, R.
    Guckenberger, M.
    Le Pechoux, C.
    Nestle, U.
    Slotman, B.
    Faivre-Finn, C.
    LUNG CANCER, 2017, 103 : S64 - S65
  • [34] Management of patients with extensive-stage small-cell lung cancer: A European survey of practice
    Haslett, K.
    De Ruysscher, D.
    Dziadziuszko, R.
    Guckenberger, M.
    Le Pechoux, C.
    Nestle, U.
    Faivre-Finn, C.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S63 - S64
  • [35] Rechallenge of immunotherapy beyond progression in patients with extensive-stage small-cell lung cancer
    Li, Lingling
    Liu, Tingting
    Liu, Qingyan
    Mu, Shuai
    Tao, Haitao
    Yang, Xuhui
    Li, Yao
    Xiong, Qi
    Wang, Lijie
    Hu, Yi
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [36] PRACTICAL APPROACHES TO THE TREATMENT OF PATIENTS WITH EXTENSIVE-STAGE SMALL-CELL LUNG-CANCER
    GRECO, FA
    HAINSWORTH, JD
    SEMINARS IN ONCOLOGY, 1994, 21 (04) : 3 - 6
  • [37] KINETICALLY SCHEDULED THERAPY FOR EXTENSIVE SMALL-CELL LUNG-CANCER
    CLAMON, GH
    MCFADDEN, DB
    WEISENFELD, M
    BELL, S
    CANCER CLINICAL TRIALS, 1981, 4 (02) : 159 - 162
  • [38] Effectiveness analysis of second line squamous non-small-cell lung cancer in real-life clinical practice
    Romero Hernandez, I.
    Martinez Bautista, M. J.
    Blanco Sanchez, G.
    Suarez Carrascosa, F. J.
    Dominguez Cantero, M.
    Gallego Munoz, C.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2016, 38 (02) : 590 - 590
  • [39] EFfectiveness and Safety Profile of Lurbinectedin in Second-Line Small Cell Lung Cancer: A Real-World Study
    Ganti, A. K.
    Allan, V.
    Merola, D.
    Estrin, A.
    Boccuti, A.
    Rengarajan, B.
    Baratta, C.
    Prince, P.
    Li, W.
    Cao, Y.
    D'Agostino, R. B., Jr.
    Poole, E. M.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S378 - S379
  • [40] Optimal drugs for second-line treatment of patients with small-cell lung cancer
    Rossi, Antonio
    Sacco, Paola Claudia
    Sgambato, Assunta
    Casaluce, Francesca
    Santabarbara, Giuseppe
    Palazzolo, Giovanni
    Maione, Paolo
    Gridelli, Cesare
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (07) : 969 - 976
12345